1. Home
  2. SWTX vs SMG Comparison

SWTX vs SMG Comparison

Compare SWTX & SMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SWTX
  • SMG
  • Stock Information
  • Founded
  • SWTX 2017
  • SMG 1868
  • Country
  • SWTX United States
  • SMG United States
  • Employees
  • SWTX N/A
  • SMG N/A
  • Industry
  • SWTX Biotechnology: Pharmaceutical Preparations
  • SMG Agricultural Chemicals
  • Sector
  • SWTX Health Care
  • SMG Industrials
  • Exchange
  • SWTX Nasdaq
  • SMG Nasdaq
  • Market Cap
  • SWTX 3.5B
  • SMG 3.2B
  • IPO Year
  • SWTX 2019
  • SMG N/A
  • Fundamental
  • Price
  • SWTX $46.67
  • SMG $57.30
  • Analyst Decision
  • SWTX Buy
  • SMG Strong Buy
  • Analyst Count
  • SWTX 7
  • SMG 6
  • Target Price
  • SWTX $56.86
  • SMG $65.83
  • AVG Volume (30 Days)
  • SWTX 4.9M
  • SMG 1.1M
  • Earning Date
  • SWTX 05-09-2025
  • SMG 04-30-2025
  • Dividend Yield
  • SWTX N/A
  • SMG 4.60%
  • EPS Growth
  • SWTX N/A
  • SMG N/A
  • EPS
  • SWTX N/A
  • SMG 0.63
  • Revenue
  • SWTX $219,670,000.00
  • SMG $3,454,700,000.00
  • Revenue This Year
  • SWTX $79.29
  • SMG N/A
  • Revenue Next Year
  • SWTX $70.79
  • SMG $1.90
  • P/E Ratio
  • SWTX N/A
  • SMG $90.93
  • Revenue Growth
  • SWTX 730.42
  • SMG 0.75
  • 52 Week Low
  • SWTX $28.21
  • SMG $45.61
  • 52 Week High
  • SWTX $62.00
  • SMG $93.90
  • Technical
  • Relative Strength Index (RSI)
  • SWTX 60.85
  • SMG 47.38
  • Support Level
  • SWTX $46.21
  • SMG $58.60
  • Resistance Level
  • SWTX $46.77
  • SMG $61.23
  • Average True Range (ATR)
  • SWTX 0.15
  • SMG 1.73
  • MACD
  • SWTX -0.05
  • SMG -0.29
  • Stochastic Oscillator
  • SWTX 85.71
  • SMG 1.96

About SWTX SpringWorks Therapeutics Inc.

SpringWorks Therapeutics Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing, and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing prevalent, genetically defined cancers. OGSIVEO, the first commercial product, is a novel, oral, selective gamma-secretase inhibitor. GOMEKLI, the second commercial product, is an oral, small molecule mitogen-activated protein kinase, or MEK, inhibitor.

About SMG Scotts Miracle-Gro Company (The)

Scotts Miracle-Gro is the largest purveyor of home lawn and gardening products in the US. The business consists of three reporting segments: US consumer, Hawthorne, and other. The US consumer segment consists of a broad range of lawncare products, including grass seed, fertilizer, and lawn-related weed, animal, and disease control. US consumer typically generates the vast majority of companywide revenue and profits. Hawthorne sells indoor gardening and hydroponic equipment, particularly to the cannabis growing industry, while the other segment primarily consists of lawn and gardening products sold in Canada. Its lawncare and gardening products are well-recognized brands in the US, including Scotts, Miracle-Gro, Roundup, Ortho, and Tomcat.

Share on Social Networks: